latest news releases from the newsroom
Amersin Life Sciences Corp.
Amersin Enters Into Termination Agreement With Chinese Joint Venture Partner
NEW YORK, Oct. 20, 2005 (PRIMEZONE) -- Amersin Life Science Corporation (OTCBB:AMLSE) announced today that it has reached a termination agreement and will be disposing of its interest in the Hubei Tongji Benda Ebei Pharmaceutical Co. Ltd. joint venture in the Hubei Province of China. Under the terms of the agreement Amersin will return its interest in the joint venture to Benda Science and Technology Company in exchange for $220,000 to be paid within six months and the return of 1.6 million shares of Amersin common stock to treasury. Additional details may be found on Form 8-K filed with the Securities and Exchange Commission this date.
Discovery Laboratories, Inc.
Discovery Labs Surfaxin Licensed in Italy by Dompe Farmaceutici
WARRINGTON, Pa., Oct. 20, 2005 (PRIMEZONE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) announced today that its development and marketing partner in Southern Europe, Laboratorios del Dr. Esteve, S.A. (Esteve) has sublicensed the distribution rights to Surfaxin(r) in Italy to Dompe Farmaceutici Spa (Dompe), a privately owned Italian company. Under this agreement Dompe will be responsible for sales, marketing and distribution in Italy of Surfaxin for the prevention and treatment of Respiratory Distress Syndrome (RDS) in premature infants.
Paragon Real Estate Equity and Investment Trust
Paragon Files Form 8-K for Bylaw Amendment
CLEVELAND, Oct. 20, 2005 (PRIMEZONE) -- Paragon Real Estate Equity and Investment Trust (AMEX:PRG) filed with the Securities and Exchange Commission a current report on Form 8-K for an amendment to its bylaws that the board of trustees approved at a recent meeting to allow Paragon to issue its shares without a physical certificate. The amendment is in accordance with Maryland General Corporation Law Section 8-203. This change does not affect shares already in certificate form until they are surrendered to Paragon's stock transfer agent.
Five Sparrows LLC
MIR Preclinical Services Highlights Imaging Technologies at Major U.S. Exhibits in November, 2005
ANN ARBOR, Mich., Oct. 20, 2005 (PRIMEZONE) -- MIR Preclinical Services (MIR) is pleased to announce that it will be highlighting its high resolution small animal PET, preclinical MRI, in vivo micro-CT, and in vivo bioluminescence and fluorescence imaging technologies at two major conference exhibits in November. The first exhibit will be at the annual meeting of the American Association of Pharmaceutical Scientists (AAPS), November 7-9 in Nashville, TN. The second exhibit will be at the 17th annual EORTC-NCI-AACR Symposium on "Molecular Targets and Cancer Therapeutics", November 15-17 in Philadelphia, PA. These technologies are described below:
Nord Resources Corporation
Nord Resources Updates Activities
DRAGOON, Ariz., Oct. 20, 2005 (PRIMEZONE) -- Nord Resources Corporation (Pink Sheets:NRDS) is pleased to announce that it has recently completed a mezzanine financing in the amount of $2.85 million with a private firm. The proceeds from the mezzanine financing will replace an existing, outstanding debt facility which would have matured and become due on October 19, 2005.
Oakley Appoints New Chief Financial Officer
FOOTHILL RANCH, Calif., Oct. 20, 2005 (PRIMEZONE) -- Oakley, Inc. (NYSE:OO) today announced that it has appointed Richard J. Shields, CPA, as its chief financial officer effective November 3, 2005. Mr. Shields, 48, will oversee the company's finance and accounting functions bringing more than 20 years of senior financial experience to his new role. He will report directly to chief operating officer Link Newcomb.
Oakley Posts 29 Percent Increase In Earnings Per Share On Record Quarterly Net Sales Of $173.4 Million
FOOTHILL RANCH, Calif., Oct. 20, 2005 (PRIMEZONE) -- Oakley, Inc. (NYSE:OO) today announced that net sales increased 15.6 percent, net income grew 31.6 percent and earnings per share increased 29.4 percent in its third quarter ended September 30, 2005 compared to the same period in 2004. Net sales grew to a quarterly record $173.4 million compared with $150.0 million in the third quarter of 2004. Net income for the third quarter totaled $15.0 million, or $0.22 per diluted share, compared with net income of $11.4 million, or $0.17 per diluted share, earned in the third quarter of 2004.
Skinny Nutritional Corp.
Creative Enterprises International, Inc. Announces National Distribution Deal with GNC
NEW YORK, Oct. 20, 2005 (PRIMEZONE) -- Creative Enterprises International, Inc., (Pink Sheets:CEII) announces the introduction of its new product, Jana Skinny Water (www.skinnywater.com) into 600 GNC stores nationwide. GNC (www.gnc.com) will debut Jana Skinny Water in its "A-stores" for availability beginning this week. Also commencing today, a radio campaign on Z100 FM, New York's number one radio station targeting woman 18-49 years of age, began branding Jana Skinny Water in the New York metropolitan market.